Breakdown | ||||
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.55B | 1.28B | 120.58M | 72.14M | 29.32M | Gross Profit |
3.78B | 1.28B | 120.58M | 72.14M | 29.32M | EBIT |
3.23B | 29.25M | 10.91M | 4.55M | -1.27M | EBITDA |
168.75M | 71.63M | 15.65M | 8.44M | 2.14M | Net Income Common Stockholders |
38.90M | 19.56M | 5.22M | 2.23M | -369.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
731.84M | 913.27M | 120.70M | 62.22M | 18.09M | Total Assets |
17.65B | 16.76B | 883.87M | 484.25M | 188.88M | Total Debt |
896.06M | 906.17M | 15.28M | 5.37M | 1.50M | Net Debt |
164.23M | -7.09M | -105.42M | -56.85M | -16.59M | Total Liabilities |
17.04B | 16.23B | 762.96M | 456.97M | 164.34M | Stockholders Equity |
540.91M | 503.57M | 120.91M | 27.28M | 24.54M |
Cash Flow | Free Cash Flow | |||
-155.27M | -130.84M | -37.17M | 34.98M | -26.18M | Operating Cash Flow |
-45.38M | -54.05M | -30.13M | 38.26M | -23.96M | Investing Cash Flow |
-113.15M | 382.83M | -8.35M | -3.28M | -2.22M | Financing Cash Flow |
-22.89M | 463.80M | 96.95M | 9.15M | -538.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | 18.97B | 10.46 | 4.41% | 25.41% | 135.28% | ||
80 Outperform | $679.53M | 18.24 | 13.58% | 3.93% | 3.26% | -0.41% | |
74 Outperform | 653.55M | 6.23 | 3.06% | 22.14% | 128.32% | ||
70 Outperform | $8.74B | 12.44 | 6.80% | 0.74% | -8.06% | -28.17% | |
66 Neutral | 8.17B | 11.31 | 1.23% | ― | ― | ||
60 Neutral | $10.96B | 10.28 | -6.73% | 2.97% | 7.74% | -12.45% |
Wesure Globalt Ltd. recently announced that a court decision has been made concerning a class action lawsuit against its subsidiary, Ayalon Insurance Company Ltd., related to a personal accident insurance policy for students. The court has dismissed Ayalon from the request for approval of the class action lawsuit, permitting the continuation of the legal process against the other parties involved, which may impact the company’s legal obligations and financial outlook.
Wesure Globalt recently held a special meeting where shareholders approved the appointment of CPA Tzila Deskal as an external director and Prof. Limor Etsioni as an independent director, with both appointments set to commence on February 14, 2025. These appointments are significant as they strengthen the company’s board of directors, potentially enhancing governance and strategic oversight, which could impact the company’s market positioning and stakeholder confidence.